Chronic Myeloid Leukaemia
Links shared publicly online about this topic
Oncology Article | chronic myeloid leukaemia
mdlinx.com — “Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial” View full resource at mdlinx.com
Most Recently Shared on August 19, 2011 at 1:56 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelph... http://t.co/lmCYrTe #oncology
NICE Appraisal Of Dasatinib And Nilotinib For Chronic Myeloid Leukaemia
medicalnewstoday.com — “The National Institute for Health and Clinical Excellence (NICE) has updated its draft guidance on the use of dasatinib (Sprycel,made by Bristol Myers-Squibb) and nilotinib (Tasigna,made by Novart” View full resource at medicalnewstoday.com
Most Recently Shared on February 9, 2010 at 5:13 pm By:
NICE Appraisal Of Dasatinib And Nilotinib For Chronic Myeloid Leukaemia http://mnt.to/3xpG #lymphoma #leukemia
NICE Appraisal Of Dasatinib And Nilotinib For Chronic Myeloid Leukaemia
medicalnewstoday.com — “The national institute for health and clinical excellence (nice) is currently appraising the use of dasatinib (made by bristol myers-squibb) and nilotinib (novartis) for chronic myeloid leukaemia ” View full resource at medicalnewstoday.com
Most Recently Shared on January 6, 2010 at 12:15 pm By:
NICE Appraisal Of Dasatinib And Nilotinib For Chronic Myeloid Leukaemia http://mnt.to/3vXP
NICE recommends two drugs for chronic myeloid leukaemia
nice.org.uk — “NICE recommends two drugs for chronic myeloid leukaemia” View full resource at nice.org.uk
Most Recently Shared on December 8, 2011 at 11:29 am By:
NICE recommends Glivec and Tasigna but not Sprycel for chronic myeloid leukaemia (CML) in new draft guidance: http://t.co/QtQaypPK
Mathematical Model Gives New Hope To Chronic Myeloid Leukaemia Patients
medicalnewstoday.com — “Doctors can now understand better chronic myeloid leukaemia (CML), including how it responds to therapy, thanks to a new mathematical model for the disease, developed by scientists in Portugal, Be” View full resource at medicalnewstoday.com
Most Recently Shared on February 23, 2010 at 2:11 pm By:
Mathematical Model Gives New Hope To Chronic Myeloid Leukaemia Patients http://mnt.to/3xYc #lymphoma #leukemia
Oncology Medical Article | Imatinib plasma trough levels in chronic myeloid leukaemia
mdlinx.com — “Oncology Medical Article: Imatinib plasma trough levels in chronic myeloid leukaemia” View full resource at mdlinx.com
Most Recently Shared on March 14, 2012 at 11:44 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Imatinib plasma trough levels in chronic myeloid leukaemia: Hematological Oncology http://t.co/raGtmh4A #oncology
Evidence to support chronic myeloid leukaemia drugs "very poor"
nice.org.uk — “Evidence to support chronic myeloid leukaemia drugs "very poor"” View full resource at nice.org.uk
Most Recently Shared on February 9, 2010 at 9:17 pm By:
Jane Sarasohn-Kahn - healthythinker Health Social Media
NICE tells drugmakers today to share in the cost of CM leukemia drugs since weak evidence- here's NICE's statement | http://bit.ly/aKvuuM
Phase 3 DASISION Trial Shows Dasatinib Achieves Higher Response Rates Than Imatinib In Chronic Myeloid Leukaemia
medicalnewstoday.com — “Barcelona, 12 June 2010: The BCR-ABL kinase inhibitor dasatinib (Sprycel, Bristol-Myers Squibb) achieves significantly higher rates of complete cytogenetic response and major molecular response th” View full resource at medicalnewstoday.com
Most Recently Shared on June 14, 2010 at 12:09 pm By:
Phase 3 DASISION Trial Shows Dasatinib Achieves Higher Response Rates Than Imatinib In Chronic Myeloid Leukaemia http://mnt.to/3DPG
NICE Final Recommendation Of Tasigna (nilotinib) For Some Ph+ Chronic Myeloid Leukaemia Patients Welcomed, UK
medicalnewstoday.com — “The decision by the National Institute for Health and Clinical Excellence (NICE) to recommend Tasigna (nilotinib) in the treatment of imatinib-resistant and imatinib-intolerant Philadelphia Chromo” View full resource at medicalnewstoday.com
Most Recently Shared on August 21, 2011 at 7:05 am By:
NICE Final Recommendation Of Tasigna (nilotinib) For Some Ph+ Chronic Myeloid Leukaemia Patients Welcomed, UK http://mnt.to/3Z6b
Price discount means NICE can recommend a new drug for chronic myeloid leukaemia
nice.org.uk — “Price discount means NICE can recommend a new drug for chronic myeloid leukaemia” View full resource at nice.org.uk
Most Recently Shared on August 23, 2011 at 10:11 pm By:
It seems Dasatinib still unavailable to UK CML patients in 2nd line until BMS agrees to price cut too, see NHS site http://ow.ly/6aYwv
NICE Final Recommendation Of Tasigna (nilotinib) For Some Ph+ Chronic Myeloid Leukaemia Patients Welcomed, UK - QualityPoint Technologies
qualitypointtech.net — “The decision by the National Institute for Health and Clinical Excellence (NICE) to recommend Tasigna (nilotinib) in the treatment of imatinib-resistant and imatinib-intolerant Philadelphia Chromosome (Ph+) chronic myeloid leukaemia (CML) was welcomed by Novartis Oncology. Although Dasatinib and high dose imatinib were appraised in the same setting, neither is recommended, with final Guidance expected to be in October 2011...” View full resource at qualitypointtech.net
Most Recently Shared on August 22, 2011 at 1:00 am By:
NICE Final Recommendation Of Tasigna (nilotinib) For Some Ph+ Chronic Myeloid Leukaemia Patients Welcomed, UK: The... http://t.co/GtzrvSG
Oncology Article | Leukaemia
mdlinx.com — “Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia” View full resource at mdlinx.com
Most Recently Shared on March 29, 2011 at 2:17 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia: British Journal o... http://bit.ly/eb9GYn #oncology
Oncology Article | acute myeloid leukaemia
mdlinx.com — “Array-based DNA methylation profiling in acute myeloid leukaemia” View full resource at mdlinx.com
Most Recently Shared on July 29, 2011 at 11:46 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Array-based DNA methylation profiling in acute myeloid leukaemia: British Journal of Haematology http://bit.ly/p92qu6 #oncology
Oncology Article | acute myeloid leukaemia
mdlinx.com — “Tyrosine kinase inhibitor insensitivity of non-cycling CD34+ human acute myeloid leukaemia cells with FMS-like tyrosine kinase 3 mutations” View full resource at mdlinx.com
Most Recently Shared on June 29, 2011 at 1:53 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Tyrosine kinase inhibitor insensitivity of non-cycling CD34+ human acute myeloid leukaemia cells with ... http://bit.ly/jKXqH4 #oncology
Oncology Article | acute myeloid leukaemia
mdlinx.com — “Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia” View full resource at mdlinx.com
Most Recently Shared on August 22, 2011 at 9:43 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for re... http://t.co/XN58t6y #oncology
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
MNT Leukemia
The latest lymphoma and leukemia news published daily. Articles from research centers, universities and prestigious journals.
-
MNT Cancer News
The latest cancer news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
